Mengel suggests adding CRDL....The following is out today from the Cannabis guru Jimmy Mengel; it's after the NASDAQ announcement CRDL made this morning....
In other cannabis news, today Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) announced a plan to uplist to the NASDAQ.
Cardiol Therapeutics is a biotechnology company specializing in the research and commercial development of novel drug therapies utilizing proprietary drug-delivery systems. The company is developing CBD medications for chronic heart failure, which affects more than 26 million people globally.
Over six million adults in Canada and the United States suffer from chronic heart failure and it remains a leading cause of death and hospitalization, with associated healthcare costs exceeding $30 billion annually in the U.S. alone.
Cardiol is already up 49% this year. I would suggest adding it to your portfolio if you haven't yet.